<ul>
<li>檢查團隊將在阿聯酋入境點駐守，以加快藥品運輸清關</li>
</ul>
<p><strong>迪拜，阿聯酋：</strong> 阿聯酋藥品管理局（EDE）宣佈成立一個由 16 個戰略合作伙伴組成的工作組，涉及阿聯酋的藥品和物流供應鏈，包括藥品製造商、醫療倉庫、儲存設施和物流提供商。</p>
<p>該工作組旨在增強國家藥品供應系統的韌性，並加強各主管部門之間的協調，以確保藥品和醫療產品在國內的持續供應，同時支持醫療行業的準備工作。</p>
<p>在阿聯酋藥品管理局主持的會議上，工作組討論了協調努力和制定主動計劃，以確保藥品和醫療產品在供應鏈各個階段的順暢流動，從製造、儲存到本地市場的分銷，使藥品行業能夠適應變化並確保供應的連續性。</p>
<p>官員們還審查了當前的藥品庫存水平，製造商和倉庫的代表確認國內市場藥品和醫療產品的供應充足。</p>
<p>與藥品供應流動相關的操作信息和技術專長也進行了交流，以支持主動規劃並提高國內藥品庫存管理的效率。</p>
<p>該工作組還將制定信息和操作數據共享機制，支持主動規劃和風險管理，增強參與實體之間的協調，並加強在操作和監管層面的決策，同時提高庫存管理效率，確保重要醫療產品的持續供應。</p>
<p>阿聯酋藥品管理局局長法蒂瑪·阿爾卡比（H.E. Dr. Fatima Al Kaabi）表示，增強藥品供應鏈的韌性是阿聯酋藥品安全框架的關鍵支柱。</p>
<p>阿爾卡比補充道：“藥品管理局將繼續完善其監管體系，並加強與醫療和物流行業合作伙伴的合作，以確保藥品和醫療產品的可持續供應，符合最高的安全、質量和有效性標準。”</p>
<p>她指出，工作組的成立證明了 EDE 與政府和私營部門合作伙伴密切合作的努力。“這一步將有助於增強藥品行業的準備能力，提高醫療系統對影響供應鏈的任何發展做出高效響應的能力，同時確保醫療服務的持續性。”</p>
<p>與此同時，阿聯酋藥品管理局局長顧問、工作組負責人瑪麗亞姆·阿爾馬茲魯伊博士表示，團隊將致力於在相關實體之間建立更有效的協調和溝通渠道，以便交換與藥品和醫療產品流動相關的操作數據和技術專長，同時支持主動規劃和風險管理。</p>
<p>阿爾馬茲魯伊補充説，提高與藥品供應鏈相關的物流操作效率是團隊的關鍵優先事項之一。</p>
<p>她表示：“從加快藥品運輸入境程序到便利醫療產品通過國家入境口岸的流動，我們致力於確保供應流暢，並在符合最高質量和安全標準的情況下，確保本地市場藥品的持續供應。”</p>
<p>阿聯酋藥品管理局澄清，將提供必要的監管便利，以實施商定的措施，包括將進口許可證的有效期延長兩個月。</p>
<p>它還補充説，其檢查團隊將在卡車入境點駐守，以加快醫療產品和用於其製造的原材料的海關清關和檢查程序，並與相關部門協調。</p>
<p>該機構表示，必要時也可以在公司倉庫內提供貨物清關服務，以加快操作程序並提高物流效率，同時確保阿聯酋醫療產品的最高安全和質量標準。</p>
<p>該工作組倡議是該機構加強與醫療和物流行業利益相關者的機構合作伙伴關係的努力的一部分，支持藥品供應的可持續性，增強國家的藥品安全，並確保藥品和醫療產品的持續供應，以滿足患者和醫療機構的需求。</p>
<p>請將您的新聞稿發送至 pressrelease.zawya@lseg.com</p>
<p>免責聲明：本新聞稿的內容由外部第三方提供。本網站不對該外部內容負責，也不控制該內容。該內容按 “現狀” 和 “可用” 基礎提供，未經過任何編輯。本網站及我們的附屬機構不保證該新聞稿中表達的觀點或意見的準確性。</p>
<p>本新聞稿僅供信息參考。內容不提供税務、法律或投資建議，也不對任何特定證券、投資組合或投資策略的適用性、價值或盈利能力發表意見。本網站及我們的附屬機構對內容中的任何錯誤或不準確之處，或因您依賴該內容而採取的任何行動不承擔任何責任。您明確同意，您對本文中信息的使用風險自負。</p>
<p>在適用法律允許的最大範圍內，本網站及其母公司、子公司、關聯公司以及各自的股東、董事、高級職員、員工、代理人、廣告商、內容提供者和許可方對您不承擔任何直接、間接、後果性、特殊、附帶、懲罰性或示範性損害賠償責任，包括但不限於利潤損失、儲蓄損失和收入損失，無論是基於過失、侵權、合同還是任何其他責任理論，即使各方已被告知可能性或可以預見到任何此類損害。</p>

<p>阿聯酋藥品機構（EDE）與 16 個合作伙伴組建了一個國家工作組，以增強阿聯酋的藥品供應鏈。該工作組旨在改善利益相關者之間的協調，確保藥品和醫療產品的可用性。它將重點關注主動規劃、風險管理和高效的物流操作。EDE 將促進監管措施，包括延長進口許可證的有效期和加快藥品運輸的海關清關。這項倡議是 EDE 致力於加強藥品安全和支持阿聯酋醫療行業韌性的承諾的一部分</p>

<ul>
<li>Inspection teams to be present at UAE entry points to speed up pharmaceutical shipment clearance</li>
</ul>
<div class="lb-trans"><ul>
<li>檢查團隊將在阿聯酋入境點駐守，以加快藥品運輸清關</li>
</ul>
</div><p><strong>Dubai, UAE:</strong> The Emirates Drug Establishment (EDE) has announced the setting up of a task force comprising 16 strategic partners involved in pharmaceutical and logistics supply chains across the UAE, including drug manufacturers, medical warehouses, storage facilities and logistics providers.</p>
<div class="lb-trans"><p><strong>迪拜，阿聯酋：</strong> 阿聯酋藥品管理局（EDE）宣佈成立一個由 16 個戰略合作伙伴組成的工作組，涉及阿聯酋的藥品和物流供應鏈，包括藥品製造商、醫療倉庫、儲存設施和物流提供商。</p>
</div><p>The task force aims to strengthen the resilience of the country’s pharmaceutical supply system and enhance coordination among competent authorities to ensure the continued availability of medicines and medical products in the country while supporting the readiness of the healthcare sector.</p>
<div class="lb-trans"><p>該工作組旨在增強國家藥品供應系統的韌性，並加強各主管部門之間的協調，以確保藥品和醫療產品在國內的持續供應，同時支持醫療行業的準備工作。</p>
</div><p>During its meeting, chaired by the Emirates Drug Establishment, the task force discussed coordinating efforts and developing proactive plans to ensure the smooth flow of medicines and medical products across all stages of the supply chain, from manufacturing and storage to distribution in the local market, enabling the pharmaceutical sector to adapt to changes and ensure continuity of supply.</p>
<div class="lb-trans"><p>在阿聯酋藥品管理局主持的會議上，工作組討論了協調努力和制定主動計劃，以確保藥品和醫療產品在供應鏈各個階段的順暢流動，從製造、儲存到本地市場的分銷，使藥品行業能夠適應變化並確保供應的連續性。</p>
</div><p>Officials also reviewed current pharmaceutical stock levels, with representatives from manufacturers and warehouses confirming sufficient supplies of medicines and medical products in the domestic market.</p>
<div class="lb-trans"><p>官員們還審查了當前的藥品庫存水平，製造商和倉庫的代表確認國內市場藥品和醫療產品的供應充足。</p>
</div><p>Operational information and technical expertise related to pharmaceutical supply movements were also exchanged, supporting proactive planning and enhancing the efficiency of drug inventory management in the country.</p>
<div class="lb-trans"><p>與藥品供應流動相關的操作信息和技術專長也進行了交流，以支持主動規劃並提高國內藥品庫存管理的效率。</p>
</div><p>The task force will also develop mechanisms for sharing information and operational data related to pharmaceutical supplies, supporting proactive planning and risk management, enhancing coordination among participating entities, and strengthening decision-making at both operational and regulatory levels, while also improving inventory management efficiency and ensuring the continued availability of vital medical products.</p>
<div class="lb-trans"><p>該工作組還將制定信息和操作數據共享機制，支持主動規劃和風險管理，增強參與實體之間的協調，並加強在操作和監管層面的決策，同時提高庫存管理效率，確保重要醫療產品的持續供應。</p>
</div><p>H.E. Dr. Fatima Al Kaabi, Director General of the Emirates Drug Establishment, said that strengthening the resilience of pharmaceutical supply chains is a key pillar of the UAE’s drug security framework.</p>
<div class="lb-trans"><p>阿聯酋藥品管理局局長法蒂瑪·阿爾卡比（H.E. Dr. Fatima Al Kaabi）表示，增強藥品供應鏈的韌性是阿聯酋藥品安全框架的關鍵支柱。</p>
</div><p>“The Establishment will continue to develop its regulatory systems and strengthen cooperation with partners across the healthcare and logistics sectors to ensure the sustainable availability of medicines and medical products in line with the highest standards of safety, quality and effectiveness,” Al Kaabi added.</p>
<div class="lb-trans"><p>阿爾卡比補充道：“藥品管理局將繼續完善其監管體系，並加強與醫療和物流行業合作伙伴的合作，以確保藥品和醫療產品的可持續供應，符合最高的安全、質量和有效性標準。”</p>
</div><p>Her Excellency noted the formation of the task force is a testament to how EDE is working closely with both government and private sector partners. “This step will help strengthen the pharmaceutical sector’s preparedness and improve the healthcare system’s ability to respond efficiently to any developments affecting supply chains while ensuring that healthcare services continue without disruption.”</p>
<div class="lb-trans"><p>她指出，工作組的成立證明了 EDE 與政府和私營部門合作伙伴密切合作的努力。“這一步將有助於增強藥品行業的準備能力，提高醫療系統對影響供應鏈的任何發展做出高效響應的能力，同時確保醫療服務的持續性。”</p>
</div><p>Meanwhile, Dr Mariam Al Mazrouei, adviser to the Director General of the Emirates Drug Establishment and head of the task force, said the team will work to develop more effective coordination and communication channels among relevant entities, enabling the exchange of operational data and technical expertise related to the movement of medicines and medical products, while supporting proactive planning and risk management.</p>
<div class="lb-trans"><p>與此同時，阿聯酋藥品管理局局長顧問、工作組負責人瑪麗亞姆·阿爾馬茲魯伊博士表示，團隊將致力於在相關實體之間建立更有效的協調和溝通渠道，以便交換與藥品和醫療產品流動相關的操作數據和技術專長，同時支持主動規劃和風險管理。</p>
</div><p>Al Mazrouei added that enhancing the efficiency of logistics operations linked to pharmaceutical supply chains is one of the team’s key priorities.</p>
<div class="lb-trans"><p>阿爾馬茲魯伊補充説，提高與藥品供應鏈相關的物流操作效率是團隊的關鍵優先事項之一。</p>
</div><p>“From accelerating procedures for the entry of pharmaceutical shipments to facilitating the movement of medical products through the country’s ports of entry, we are committed to ensuring smooth supply flows and the continued availability of medicines in the local market in line with the highest standards of quality and safety,” she said.</p>
<div class="lb-trans"><p>她表示：“從加快藥品運輸入境程序到便利醫療產品通過國家入境口岸的流動，我們致力於確保供應流暢，並在符合最高質量和安全標準的情況下，確保本地市場藥品的持續供應。”</p>
</div><p>The Emirates Drug Establishment clarified it will provide the necessary regulatory facilitation to implement the agreed measures, including extending the validity of import permits by an additional two months.</p>
<div class="lb-trans"><p>阿聯酋藥品管理局澄清，將提供必要的監管便利，以實施商定的措施，包括將進口許可證的有效期延長兩個月。</p>
</div><p>It added that its inspection teams will be present at truck entry points to speed up customs clearance and inspection procedures for medical products and raw materials used in their manufacture, in coordination with relevant authorities.</p>
<div class="lb-trans"><p>它還補充説，其檢查團隊將在卡車入境點駐守，以加快醫療產品和用於其製造的原材料的海關清關和檢查程序，並與相關部門協調。</p>
</div><p>The Establishment stated that shipment clearance services may also be provided within company warehouses when needed to accelerate operational procedures and improve logistics efficiency, while ensuring the highest safety and quality standards for medical products in the UAE.</p>
<div class="lb-trans"><p>該機構表示，必要時也可以在公司倉庫內提供貨物清關服務，以加快操作程序並提高物流效率，同時確保阿聯酋醫療產品的最高安全和質量標準。</p>
</div><p>The task force initiative falls under the establishment’s efforts to strengthen institutional partnerships with stakeholders across the healthcare and logistics sectors, supporting the sustainability of pharmaceutical supplies, enhancing drug security in the country, and ensuring the continued availability of medicines and medical products to meet the needs of patients and healthcare facilities.</p>
<div class="lb-trans"><p>該工作組倡議是該機構加強與醫療和物流行業利益相關者的機構合作伙伴關係的努力的一部分，支持藥品供應的可持續性，增強國家的藥品安全，並確保藥品和醫療產品的持續供應，以滿足患者和醫療機構的需求。</p>
</div><p>Send us your press releases to pressrelease.zawya@lseg.com</p>
<div class="lb-trans"><p>請將您的新聞稿發送至 pressrelease.zawya@lseg.com</p>
</div><p>Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.</p>
<div class="lb-trans"><p>免責聲明：本新聞稿的內容由外部第三方提供。本網站不對該外部內容負責，也不控制該內容。該內容按 “現狀” 和 “可用” 基礎提供，未經過任何編輯。本網站及我們的附屬機構不保證該新聞稿中表達的觀點或意見的準確性。</p>
</div><p>The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.</p>
<div class="lb-trans"><p>本新聞稿僅供信息參考。內容不提供税務、法律或投資建議，也不對任何特定證券、投資組合或投資策略的適用性、價值或盈利能力發表意見。本網站及我們的附屬機構對內容中的任何錯誤或不準確之處，或因您依賴該內容而採取的任何行動不承擔任何責任。您明確同意，您對本文中信息的使用風險自負。</p>
</div><p>To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.</p>
<div class="lb-trans"><p>在適用法律允許的最大範圍內，本網站及其母公司、子公司、關聯公司以及各自的股東、董事、高級職員、員工、代理人、廣告商、內容提供者和許可方對您不承擔任何直接、間接、後果性、特殊、附帶、懲罰性或示範性損害賠償責任，包括但不限於利潤損失、儲蓄損失和收入損失，無論是基於過失、侵權、合同還是任何其他責任理論，即使各方已被告知可能性或可以預見到任何此類損害。</p>
</div>

ZAWYA-PRESSR：阿聯酋藥品機構成立國家工作組，支持可持續的藥品供應鏈